Article Details
Retrieved on: 2021-08-11 20:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
We look forward to starting the randomization part of the trial phase globally,” Neil Fleshner, MD, chief medical officer of POINT Biopharma, the ...
Article found on: www.urologytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here